论文部分内容阅读
目的:本文就核苷类药物联合中药治疗早期肝硬化的临床疗效进行分析与探讨。方法:选择我院2014年2月至2015年2月期间收治的早期肝硬化患者74例,其后按照入院就诊时间平均分为参照组(n=37)和研究组(n=37)。研究组患者予以核苷类药物联合中药治疗,参照组患者仅接受核苷类药物治疗,最后将对比参照组和研究组的临床治疗效果。结果:经不同方法治疗后,研究组患者的临床治疗总有效率高于参照组,肝功能指标的改善程度同参照组进行比较,前者明显较好,组间由统计学分析后,差异显著。结论:在早期肝硬化治疗中采用核苷类药物联合重中药治疗,疗效确切,具有临床应用价值。
Objective: In this paper, nucleoside drugs combined with traditional Chinese medicine in the treatment of early cirrhosis clinical analysis and discussion. Methods: A total of 74 patients with early cirrhosis who were admitted to our hospital from February 2014 to February 2015 were selected and divided into the reference group (n = 37) and the study group (n = 37) according to the mean time of admission. Patients in the study group were treated with nucleoside drugs in combination with traditional Chinese medicine. Patients in the reference group were treated with nucleoside drugs only. Finally, the clinical effects of the reference group and the study group were compared. Results: After treatment by different methods, the total effective rate of clinical treatment in study group was higher than that in reference group. The degree of improvement of liver function was compared with that of reference group. The former was better and the latter was statistically significant. Conclusion: The treatment of early cirrhosis with nucleoside drugs combined with heavy traditional Chinese medicine treatment, the exact effect, with clinical value.